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Summary 
Substantial increases in both 3/3-OH sterol and fatty acid synthesis were 
observed after concanavalin A addition to mouse spleen lymphocytes cultured 
in serum-free media. The rate of sterol synthesis increased linearly up to 60 h. 
The rate of fatty acid synthesis increased up to 20 h, reaching a plateau in syn- 
thetic activity which was the maintained. CO* production from acetate was 
slightly stimulated by concanavalin A. In contrast to sterol and fatty acid syn- 
thesis, the rate of COz production in both mitogen-stimulated and resting cul- 
tures declined with time. Dibutyryl cyclic AMP had a strong inhibitory effect 
on concanavalin A-stimulated sterol and fatty acid synthesis from acetate, but 
only a slight effect on CO2 production. Delayed addition of dibutyryl cyclic 
AMP resulted in reduced inhibition. The data suggest a sequence of initiation 
for fatty acid and sterol synthesis prior to DNA synthesis and a possible regula- 
tory role of cyclic AMP in this initiation. The results support the hypothesis 
that lymphocyte activation is sequential within the spleen cell population and 
is accompanied by fatty acid and sterol synthesis. 
Introduction 
Mouse spleen lymphocytes in serum-free culture are stimulated by the plant 
lectin concanavalin A to increase the rate of DNA synthesis by as much as 
lOOO-fold over the rate in resting cultures [ 1,2]. Lectin stimulation of lympho- 
cytes may be analogous to immunological activation [ 31. The ability to activate 
lymphocytes in serum-free culture provides an excellent system for studying 
G,-G,-S transitions of the cell cycle [ 41. 
* To whom correspondence should be sent. 
39 
Previous observations in this and other laboratories have shown that cyclic 
AMP and its permeable derivatives are inhibitory to lymphocyte activation 
[1,2,4,5]. The work described in this communication implicates the involve- 
ment of 3/3-OH sterols and fatty acids in lymphocyte activation and suggests 
that cyclic AMP may exert metabolic regulation on pathways of acetate 
metabolism during lymphocyte activation. 
Materials and Methods 
Spleen cells from C3H-F mice were prepared as described by Chambers et al. 
[l]. Freshly dissected spleen cells were washed three times in phosphate- 
buffered saline and then suspended in serum-free RPM1 1640 (obtained from 
the University of California Cell Culture Facility, San Francisco) containing 
antibiotics, at an initial cell density of 5 - lo6 cells/ml. The lymphocyte cul- 
tures were incubated at 37°C in a humidified 5% COJ95% air atmosphere. An 
initial decline in cell number was observed during the first lo-20 h in the 
serum-free cultures but no further change in viability, as determined by the 
ability of cells to exclude Trypan blue, was seen during the course of the experi- 
ment. Cell viability remained constant at approx. 3 - 10” cells/ml. Cultures were 
activated with concanavalin A (0.5 Erg/ml from Miles-Yeda, Elkhart, Ind.). This 
concentration of concanavalin A was found to be maximally stimulatory as 
reported previously [ 11. Concentrations of concanavalin A greater than 1 pg/ml 
in serum-free culture resulted in increased cellular toxicity. Dibutyryl cyclic 
AMP (obtained from the Sigma Chemical Co., St. Louis, MO.) was maximally 
inhibitory at concentrations greater than 2 - 10m4 M, and was routinely used at 
5 - 10m4 M. This concentration of cyclic nucleotide has no effect on cell viabil- 
ity. The rate of [3H]thymidine incorporation into DNA was measured by pre- 
cipitating sonicated lymphocyte lysates with 10% trichloroacetic acid as pre- 
viously described [l]. 2.5 FCi [3H]thymidine (specific activity 13 Ci/mmol, 
Schwartz-Mann, Orangeburg, N.Y.) per ml of culture was added 2 h before 
termination of the experiment. The rates of 3@-OH sterol synthesis (assayed as 
digitonin-precipitable sterol), fatty acid synthesis and CO2 evolution were 
measured after addition of 5 pCi/ml of culture of [l-14C]acetate (specific activ- 
ity 58.3 Ci/mol, New England Nuclear, Boston, Mass.) at a concentration of 
8.6 - lo-’ M for 4 h by the method of Kandutsch and Saucier [6]. Each data 
point represents the mean value of triplicate cultures, and each experiment was 
repeated at least three times. 
Results 
The temporal study of [3H]thymidine incorporation into DNA (Fig. 1) 
showed that DNA synthesis began to increase about 20 h after concanavalin A 
addition. This finding is in agreement with observations by Loeb et al. [7]. The 
rate of synthesis continued to increase for at least 65 h, at which point the 
experiment was terminated. When dibutyryl cyclic AMP (5 - 10m4 M) was added 
with concanavalin A, the rate of [‘Hlthymidine incorporation was greatly 
reduced (90% at 45 h after a 2 h pulse). Neither resting cultures nor resting cul- 
tures containing dibutyryl cyclic AMP showed any change in the rate of [ 3H]- 
40 
L 
- Con A 
o--o Con A+DBcAMP 
o--O Resting 
O..O R$sti~g+D5~AMP 
IO 20 30 40 50 60 
Time (Hours) Afler Con A Addition 
e---e Con A 
- Con A+DBcAh4 
a- - -0 Resting 
4000 
1A 
0’ ***O Resting +DBcAli 
IO 20 30 40 50 60 
Tuna (HoursI After Con A Addition 
Fii. 1. The effect of concanavahn A stimulation on DNA synthesis. Cells were treated as described in 
Materials and Methods. 5. lo6 lymphocytes/ml were incubated in the presence of 0.5 pg concanavalin A 
(Con A) and 0.5 mM dibutyryl cyclic AMP (DBc AMP)fml of culture, which were added to the culture 
media at the beginning of the experiment. DNA synthesis was measured by processing precipitated DNA 
after pulsing the cultures with 13H]thymidine as described in Materials and Methods. 
Fig. 2. (A and B) The effect of concanavalht A stimulation on cholesterol synthesis. Cells were treated as 
described in Fig. 1 and Materials and Methods. Concanavahn A (Con A) and dibutyryl cyclic AMP (DBc 
AMP) were added at the beginning of the experiments. Cholesterol was assayed as described in Materials 
and Methods. 
thymidine incorporation during the course of the experiment. 5’-Adenosine 
monophosphate or sodium butyrate, added at equivalent concentrations did 
not effect the r3H Jthymidine incorporation of resting cells or concanavdin 
A-activated cells. 
Parallel experiments designed to demonstrate the rates of [“Clacetate 
incorporation into sterols, fatty acids and CO* were performed. Concanavalin A 
addition to lymphocyte cultures resulted in enhanced sterols synthesis and this 
enhancement occurred prior to concanavalin A-induced DNA synthesis 
(Fig. 2A). The rate of sterol synthesis continued to increase in a linear fashion 
for at least 65 h (Fig. 2B). Dibutyryl cyclic AMP added concomitantly with 
con~nava~~ A resulted in a reduction in the rate of [14C]acetate incorporation 
into sterol. The extent of inhibition at 45 h was 84%. The rate of [ “C]acetate 
incorporation into sterol did not change for resting cultures containing dibut- 
yryl cyclic AMP (Figs. 2A and 2B). The results shown in Fig. 2A indicate that 
enhanced sterol synthesis began at 8-12 h following concanavalin A addition. 
Figs. 3A and 3B show the incorporation of [14C]acetate into saponifiable 
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Fig. 3. (A and B) The effect of concanavalin A stimulation on fatty acid synthesis. Cells were treated as in 
Fig. 2, and [14Clacetate incorporation into fatty acids was assayed as de&bed in Materials and Methods. 
fatty acids after the addition of concanavalin A to lymphocyte cultures. By 
22 h, the rate of concanavalin A-stimulated fatty acids synthesis was 20-fold 
greater than the resting rate and was maintained at this elevated rate up to 
65 h. Dibutyryl cyclic AMP inhibited the incorporation of [i4C]acetate into 
concanavalin A-stimulated fatty acids by 88% at 45 h. A comparison of 
Figs. 2A and 3A show that this stimulation of acetate incorporation into fatty 
acids began prior to the increase in sterol synthesis. 
Concanavalin A stimulated the production of 14C02 from [ 14C]acetate only 
2-fold (Fig. 4). However, CO* production gradually decreased under all experi- 
mental conditions and the cause of this decrease is not clear. The situation 
could be explained by a decrease in the rate of metabolism of acetate through 
the tricarboxylic acid cycle, in cells maintained in serum-free media. If this 
hypothesis is valid, the fall in COz production is apparently independent of 
concanavalin A-mediated effects on fatty acid and sterol biosynthesis. 
In order to provide further insight into the nature of the cyclic AMP response, 
we have examined the temporal relationship of dibutyryl cyclic AMP addition to 
concanavalin A-stimulated lymphocytes with respect to fatty acid synthesis, 
sterol synthesis and DNA synthesis. The observations noted above, suggested a 
sequential order for cyclic AMP effects on these metabolic processes. The data 
of Fig. 5 demonstrate the effects of delayed addition of dibutyryl cyclic AMP 
on concanavalin A-stimulated DNA, fatty acid and sterol synthesis. A study of 
DNA synthesis revealed that when dibutyryl cyclic AMP was added concomi- 
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Fig. 4. The effect of concanavalin A stimulation on CO2 production. Cells were treated as in Fig. 2. and 
14C02 production was assayed as described in Materials and Methods. 
Fig. 5. The effects of delayed addition of dibutyryl cyclic AMP on concanavalin A stimulation. Cells were 
treated as descnied in Fig. 1, except that 0.5 mM dibutyryl cyclic AMP (DBc AMP) was added at the 
indicated time points after the addition of concanavalin A (Con A). DNA synthesis. cholesterol synthesis 
and fatty acid syntheis were assayed as described in Materials and Methods. 
tantly with concanavalin A, a maximal inhibition of 90% occurred, as observed 
in previous work with Balb/C mice [ 11. When dibutyryl cyclic AMP was added 
2-6 h after concanavalin A, maximal inhibition was still observed. However, 
additions of dibutyryl cyclic AMP after 6 h resulted in decreased inhibition 
with time. Similar effects were observed for fatty acid and sterol synthesis, but 
in these cases maximum inhibition occurred only when dibutyryl cyclic AMP 
was added at 2 h or before. After 2 h, the inhibitory effects declined gradually 
as a function of the time of dibutyryl cyclic AMP addition. 
The observed effects of delayed addition of dibutyryl cyclic AMP on 
mitogen-induced DNA synthesis are in agreement with the report of Smith et 
al. [8], who concluded that dibutyryl cyclic AMP acts at an early phase of 
lymphocyte transformation; this also compliments previous observations in this 
laboratory [ 41. Our data demonstrate that dibutyryl cyclic AMP inhibits sterol 
and fatty acid synthesis early in the G, phase of lymphocyte transformation. 
Discussion 
The data presented in this study show that concanavalin A activation of 
mouse spleen lymphocytes is accompanied by a pronounced increase in both 
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3&OH sterol and fatty acid synthesis. Sterol synthesis increases at least 8 h 
before DNA synthesis. Fatty acid synthesis increases before sterol synthesis. 
Dibutyryl cyclic AMP inhibits the biosynthesis of all three of these products. 
The decreasing effect of dibutyryl cyclic AMP when added at times after 
concanavalin A supports the hypothesis by Gunther et al. [9] that the cells, or 
subpopulation of cells, are sequentially committed to activation in the presence 
of lectin. 
An argument consistent with the data presented above is that dibutyryl 
cyclic AMP inhibition of DNA synthesis is not tightly coupled to parallel regu- 
lation of fatty acid and sterol biosynthesis but that DNA synthesis has a 
requirement for enhanced fatty acid and/or sterol biosynthesis. Alternatively, 
dibutyryl cyclic AMP may regulate different events in the proliferative program 
in parallel. Nevertheless, the hypothesis by Chen et al. [lo] that increased 
sterol synthesis may be a prerequisite for DNA synthesis in mitogen-stimulated 
lymphocytes is supported by this data. The possibility exists that the inhibitory 
effect of dibutyryl cyclic AMP on DNA synthesis may relate to prior inhibition 
of sterol or fatty acid synthesis, and that the synthesis of sterol or its precur- 
sors may be important in the regulation of the cell’s proliferative program. 
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